The relationship between circulating fibrinogen and lipoprotein (a) levels in patients with primary dyslipidemia

被引:10
|
作者
Ganotakis, Emmanuel S.
Gazi, Irene F.
Papadakis, John A.
Jagroop, I. Anita
Nair, Devaki R.
Mikhailidis, Dimitri P.
机构
[1] Royal Free & Vet Coll Med Sch, Dept Clin Biochem, Vasc Dis Prevent Clin, London NW3 2QG, England
[2] Royal Free Hosp, Hampstead NHS Trust, Dept Clin Biochem, Vasc Dis Prevent Clin, London NW3 2QG, England
[3] Univ Crete, Univ Hosp Heraklion, Sch Med, Dept Internal Med, Iraklion, Crete, Greece
关键词
cardiovascular risk; dyslipidemia; fibrinogen; lipoprotein (a); smoking; CORONARY-HEART-DISEASE; BEZAFIBRATE INFARCTION PREVENTION; CARDIOVASCULAR RISK-FACTORS; PLASMA-FIBRINOGEN; MYOCARDIAL-INFARCTION; VASCULAR-DISEASE; ELEVATED LIPOPROTEIN(A); ARTERY DISEASE; INTERMITTENT CLAUDICATION; ANTIHYPERTENSIVE THERAPY;
D O I
10.1177/1076029606296256
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The correlation between 2 predictors of vascular events, plasma fibrinogen and serum lipoprotein (a), was evaluated in patients referred to a specialist clinic because of primary hyperlipidemia. A significant correlation existed between fibrinogen and lipoprotein (a) in nonsmokers but not in smokers. Plasma fibrinogen concentration correlated positively and significantly with serum lipoprotein (a) levels in men nonsmokers without cardiovascular disease and in women nonsmokers with cardiovascular disease. Nonsmoker women without cardiovascular disease had significantly higher plasma fibrinogen (3.63 g/L versus 3.07 g/L, P <.0001) than the corresponding men. Nonsmoker women with and without cardiovascular disease had significantly higher lipoprotein (a) levels than the corresponding groups of men (0.36 versus 0.18 g/L; P=.0015 and 0.40 versus 0.26 g/L; P=.008), respectively The relationship between fibrinogen and lipoprotein (a) levels alters markedly depending on the population selected. This relationship is influenced by gender, the presence of cardiovascular disease and smoking status.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 50 条
  • [31] The relationship between lipoprotein(a) and cardiovascular events in acute coronary syndrome patients with and without chronic kidney disease
    Li, Qing
    Chen, Yinong
    Yu, Luyao
    Zhu, Longyang
    Wang, Zhe
    Jiao, Siqi
    Wu, Chao
    Tu, Yimin
    Wu, Yaxin
    Guo, Ziyu
    Gao, Yanxiang
    Zheng, Jingang
    Sun, Yihong
    ATHEROSCLEROSIS, 2022, 349 : 204 - 210
  • [32] Influence and interaction of diabetes and lipoprotein (a) serum levels on mortality of patients with peripheral artery disease
    Maca, T.
    Mlekusch, W.
    Doweik, L.
    Budinsky, A. C.
    Bischof, M.
    Minar, E.
    Schillinger, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2007, 37 (03) : 180 - 186
  • [33] Assessing the relationship between lipoprotein(a) levels and blood pressure among hypertensive patients beyond conventional measures. An observational study
    Vazquez-Agra, Nestor
    Cruces-Sande, Anton
    Barbosa-Gouveia, Sofia
    Lopez-Paz, Jose-Enrique
    Camafort, Miguel
    Casariego-Vales, Emilio
    Pose-Reino, Antonio
    Hermida-Ameijeiras, Alvaro
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [34] Fibrinogen, lipoprotein (a) and lipids in patients with erectile dysfunction - A preliminary study
    Sullivan, ME
    Miller, MAW
    Bell, CRW
    Jagroop, IA
    Thompson, CS
    Khan, MA
    Morgan, RJ
    Mikhailidis, DP
    INTERNATIONAL ANGIOLOGY, 2001, 20 (03) : 195 - 199
  • [35] Association Between ApoE Status, Circulating Vitamin A and Vitamin E Levels with Dyslipidemia in Aging Adults
    Ma, Xiaojun
    Guo, Yujie
    Li, Pengfei
    Xu, Jingjing
    Gao, Yanyan
    Ren, Xiuwen
    Van Halm-Lutterodt, Nicholas
    Yuan, Linhong
    ARCHIVES OF MEDICAL RESEARCH, 2021, 52 (07) : 703 - 712
  • [36] Effect of simvastatin and fluvastatin on plasma fibrinogen levels in patients with primary hypercholesterolemia
    Okopien, B
    Krysiak, R
    Madej, A
    Belowski, D
    Zielinski, M
    Kowalski, J
    Herman, ZS
    POLISH JOURNAL OF PHARMACOLOGY, 2004, 56 (06): : 781 - 787
  • [37] Lipoprotein(a) and fibrinogen as predictors of complications in patients with acute coronary syndrome
    Carvajal Sanchez, Pedro A.
    Correa Morales, Ana M.
    Reyes Hernandez, Luis M.
    Diaz Benitez, Rosa E.
    Gonzalez Rivera, Enma M.
    Garcia Marquez, Misleidis
    CORSALUD, 2015, 7 (04): : 275 - 284
  • [38] Association study between variants in the fibrinogen gene cluster, fibrinogen levels and hypertension: Results from the MONICA/KORA study
    Kolz, Melanie
    Baumert, Jens
    Gohlke, Henning
    Grallert, Harald
    Doering, Angela
    Peters, Annette
    Wichmann, H. -Erich
    Koenig, Wolfgang
    Illig, Thomas
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (02) : 317 - 324
  • [39] Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke
    Siegerink, B.
    Rosendaal, F. R.
    Algra, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (03) : 385 - 390
  • [40] RELATIONSHIP BETWEEN INSULIN LEVELS WITH FIBRINOGEN E PARAMETERS DEFINING THE METABOLIC SYNDROME
    David Barroso, C.
    Espinosa, Joselyn
    Hember Vicci, V.
    Rita Marchi, C.
    Oscar Castillo, B.
    COMUNIDAD Y SALUD, 2014, 12 (02) : 8 - 17